Using pan-sarcoma multiomic analysis for identifying sarcoma subtypes with immunogenic potential


Galina Lagos, Roman Groisberg, Andrew Elliott, Phillip Walker, Don S. Dizon, Margaret von Mehren, Jim Abraham, Kirsten Leu, Bradley DeNardo, Eugenia Girda, Jonathan C. Trent

Key Finding:

Sarcoma subtypes previously demonstrated as immune checkpoint inhibitor responsive have high T cell inflamed score (TIS), suggesting other sarcomas with high TIS may be responsive as well. 

Download Publication